The UN General Assembly on Wednesday (March 3) unanimously adopted a resolution tabled by India along with other countries including Bangladesh, Kenya and Nepal to mark...
Covaxin is one of the two COVID-19 vaccines to have got emergency use license in India and is being used in India’s vaccination programme
The researchers noted that the annual cuts of 0.16 billion tonnes of CO2 are only 10 per cent of the 1-2 billion tonnes of CO2 cuts...
World Wildlife Day is observed to celebrate and raise awareness about the world's wild animals and plants and the threats they are facing due to human...
Covishield, a locally manufactured version by Pune’s Serum Institute of India and the indigenous Covaxin, from the Hyderabad-based company Bharat Biotech are the two COVID-19 vaccines...
The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus seven cases observed in...
The Centre urged the states and the UTs to ensure adequate allocation of COVID-19 vaccines to all hospitals, government as well as private, for the entire...
Speaking at the Global Bio-India 2021, World Health Organization's Chief Scientist Soumya Swaminathan said that the fight against the coronavirus pandemic is at a very critical...
Scientists say that in order to meet the Paris climate accord’s goal of keeping average temperatures from rising by 2 degrees Celsius compared to pre-industrial times,...
A government survey suggests its actual COVID-19 cases may be around 300 million, as many young people showed no symptoms
On March 1, COVID vaccination was rolled out for people above 60 and those above 45 years of age with comorbidities
The second phase of the nationwide COVID-19 vaccination drive for age-appropriate population groups (people above 60 and those with comorbidities above 45) began on March 1